Title
Management of Malignant Pleural Effusions
Authoring Organizations
Publication Month/Year
October 3, 2018
Last Updated Month/Year
October 4, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
This document aims to provide practicing clinicians with the synthesis of latest evidence along with recommendations to improve patient centered outcomes.
Target Patient Population
Patients with a malignant pleural effusion (MPE)
PICO Questions
In Patients with Known or Suspected MPE, Should Thoracic Ultrasound Be Used to Guide Pleural Interventions?
In Patients with Known or Suspected MPE Who Are Asymptomatic, Should Pleural Drainage Be Performed?
Should the Management of Patients with Symptomatic Known or Suspected MPE Be Guided by Large-Volume Thoracentesis and Pleural Manometry?
In Patients with Symptomatic MPE with Known or Suspected Expandable Lung and No Prior Definitive Therapy, Should IPCs or Chemical Pleurodesis Be Used as First-Line Definitive Pleural Intervention for Management of Dyspnea?
In Patients with Symptomatic MPE Undergoing Talc Pleurodesis, Should Talc Poudrage or Talc Slurry Be Used?
In Patients with Symptomatic MPE with Nonexpandable Lung, Failed Pleurodesis, or Loculated Effusion, Should an IPC or Chemical Pleurodesis Be Used?
In Patients with IPC-associated Infection (Cellulitis, Tunnel Infection, or Pleural Infection), Should Medical Therapy Alone or Medical Therapy and Catheter Removal Be Used?
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room
Intended Users
Nurse, nurse practitioner, physician, physician assistant, respiratory therapist
Scope
Diagnosis, Assessment and screening, Management
Diseases/Conditions (MeSH)
D010996 - Pleural Effusion, D016066 - Pleural Effusion, Malignant
Keywords
malignant pleural effusion, MPE